Stay updated on Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.

Latest updates to the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now indicates a new revision tag: v3.6.5, and the previous v3.6.4 tag has been removed. This reflects a routine platform update without changes to the study content or how users interact with the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3. This indicates a site version update and does not change the study content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page's revision metadata was updated from v3.6.0 to v3.6.3, indicating a newer version of the study record.SummaryDifference0.1%

- Check67 days agoChange DetectedNew user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note ('No longer looking for participants') have been added to the page. The Intervention header has been renamed to Intervention/Treatment and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check75 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5. This reflects a minor version update to the page/documentation and does not alter study data or displayed content.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, introducing a new revision tag for the page. This reflects a minor update to the page's metadata without altering the study details or visible content.SummaryDifference0.1%

Stay in the know with updates to Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.